Investigation of the effect of nicotinamide riboside on primary human bone-marrow derived mesenchymal stromal cells in vitro

Dzafo, E.; May, Rahel Deborah; Müller, Eliane Jasmine; Baertschi, S.; Naveiras, O.; Benneker, Lorin Michael; Gantenbein, Benjamin (2019). Investigation of the effect of nicotinamide riboside on primary human bone-marrow derived mesenchymal stromal cells in vitro. In: TERMIS European Chapter Meeting 2019. 27th-31st May 2019.

[img] Text
Emina Termis 2019.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (153kB)

INTRODUCTION: Mesenchymal stromal cells (MSC) have been identified as important cell-based therapy candidates for cartilage, bone and intervertebral disc diseases [1]. During prolonged in vitro expansion prior to administration, MSC become senescent which impairs their therapeutic potential [2]. Here, we aimed to investigate whether extracellular nicotinamide riboside (NR) is beneficial for MSC expansion with respect to delaying the senescence, improving cellular activity and growth kinetics. METHODS: MSC were isolated from human bone marrow aspirates by gradient centrifugation of the bone marrow and subsequent expansion in α-MEM + 10% fetal bovine serum + 2.5 ng/ml bFGF2. The cytotoxicity of NR was measured at day 4 for 29 concentrations in a range from 5 nM to 4 mM. The long-term effects of NR were tested at concentrations of 10, 100 and 1,000 μM by measuring the population doubling level (PDL), relative confluency (real-time live-cell imaging with IncuCyte S3 ® ), mitochondrial activity by resazurin reduction, senescence-associated β-galactosidase assay (SA-β-gal) and NAD/NADH ratio. RESULTS & DISCUSSION: MSC treated with 3 and 4 mM NR had a significantly higher mitochondrial activity at day 4 than the negative control (p=0.0027 and p<0.0001 respectively, N=3). However, in the weeks 3 to 8, cells treated with ≥100 μM NR died reaching a maximum PDL of 13.43 (N=4). In two donors, the experimental group with 10 μM NR reached a 2-fold higher PDL than the negative control. The relative confluency at passage (P) 2 after 6 days in culture was higher with 10 μM NR compared to the negative control (35.00 ± 9.29% and 26.19 ± 5.41% respectively, mean ± SD, N=2). The mitochondrial activity was significantly higher with 10 μM NR at P4, P8 and P10 (p<0.01, N=4). At all passages, the percentage of SA-β-gal positive cells was under 5%, except in the negative control medium at P11 (18.17% ± 18.18%, mean ± SD, N=1). All experimental groups treated with NR had a higher NAD/NADH ratio which exhibited a dose-dependent trend (N=1). CONCLUSIONS: Extracellular NR elevated the intracellular NAD/NADH ratio. NR is not cytotoxic within 4 days of culture at concentrations up to 4 mM. Long-term culture with 10 μM NR improved the growth kinetics markedly in two donors. ACKNOWLEDGEMENTS: Financial support was received by the Competence Center for Applied Biotechnology and Molecular Medicine (CABMM) start-up grant to BG. REFERENCES [1] Vedicherla S et al. J Orthop Res. 2017; 35(1):8-22 [2] Turinetto V et al. Int J Mol Sci. 2016;17(7):1164.

Item Type:

Conference or Workshop Item (Poster)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology
04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Orthopaedic Surgery
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Pathologie > Forschungsgruppe Dermatologie

UniBE Contributor:

May, Rahel Deborah; Müller, Eliane Jasmine; Benneker, Lorin Michael and Gantenbein, Benjamin

Subjects:

600 Technology > 610 Medicine & health
500 Science
500 Science > 570 Life sciences; biology

Language:

English

Submitter:

Benjamin Gantenbein

Date Deposited:

04 Sep 2019 15:08

Last Modified:

03 Nov 2019 02:56

Additional Information:

eCM Periodical, TERMIS EU Abstracts

BORIS DOI:

10.7892/boris.132991

URI:

https://boris.unibe.ch/id/eprint/132991

Actions (login required)

Edit item Edit item
Provide Feedback